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Background: LDL apheresis should be considered in patients with familial hypercholesterolemia (FH) who have not achieved lipid goals on 
maximum pharmacotherapy. The acute dramatic reduction in LDL after apheresis provides a unique perspective on the dynamics of inflammatory 
and lipid substrates.
Methods: The INFLAME Study is a pilot study focused on the rebound kinetics of lipid, oxidative and inflammatory markers over a 48 hour period 
following an LDL apheresis procedure. FH patients on maximum pharmacotherapy undergoing LDL apheresis were identified and non-consecutively 
enrolled. C-reactive protein (CRP), LDL cholesterol (LDL), lipoprotein-associated phospholipase A2 mass (PLAC), lipoprotein a (Lp(a)), and 
apolipoprotein B (apoB) were measured pre- and post-apheresis at multiple time points during an inpatient diet-controlled stay.
Results: 8 FH patients (7 heterozygous, 1 homozygous; 6 female, 2 male) with a mean age of 48 ± 17 years, and body mass index of 28.4 ± 5.2 
kg/m2 were studied. Mean % decrease post-apheresis was 72.1% for LDL, 71.8% for apoB, 60.4% for Lp(a), 43.8% for PLAC, and 61.4% for CRP. 
Compared to pre-apheresis levels, mean percent recovery at 12, 24 and 48 hours post-apheresis for: LDL was 31.1%, 37.5%, and 49.7%; apoB 
was 33.0%, 40.7%, and 52.7%; Lp(a) was 43.4%, 51.7%, and 70.4%; PLAC was 57.4%, 73.0%, and 78.4%; and CRP was 90.5%, 134%, and 120%, 
respectively. LDL had the highest correlation to apoB in rate change acutely (r = 0.88, 24 hours), and at 48 hours (r = 0.94). CRP had the highest 
correlation to PLAC in rate change acutely (r = 0.82, 24 hours), over 48 hours (r = 0.83), and independent of meals (r = 0.90, 24 vs. 48 hours). 
Recovery rates for CRP and PLAC did not correlate with those of LDL or apoB.
Conclusions: Following the dramatic acute effect of apheresis, our data indicates a rapid rebound in CRP and PLAC that precedes lipid recovery. 
In contrast to the linear recovery of LDL, both CRP and PLAC exhibit biphasic rebound with CRP returning to pre-procedure levels at the fastest rate. 
These data are consistent with distinct regulatory processes for CRP and PLAC as inflammatory markers and the presence of a high inflammatory 
state in these patients, independent of LDL levels.
